Business Description
Biocept was a San Diego-based company that specialized in blood and spinal fluid tests to detect cancer-related genetic changes, helping doctors choose the right treatments for patients with various cancers including breast, lung, and colorectal cancer. The company served a wide range of medical specialists and also supported drug developers with research and clinical trial testing. After operating since 1997, Biocept filed for bankruptcy liquidation in October 2023.
